Skip to main content

Table 1 Agents used in treatment of angioimmunoblastic T-cell lymphoma

From: Chemotherapy combined with radiotherapy for successful treatment of angioimmunoblastic T-cell lymphoma: a case report

Agent [reference]

AITL (no.)

ORR/CR (%)

Median PFS (months)

Romidepsin [15]

27

30/19

4

Pralatrexate [16]

13

8/NR

3.5

Bendamustine [17]

32

NR

3.6

Brentuximab vedotin [18]

13

54/38

2.6

Lenalidomide [19]

7

29/0

3.2

CHOP [20]

33

NR/61

26

  1. Abbreviations: AITL Angioimmunoblastic T-cell lymphoma, CR Complete response, ORR Overall response rate, PFS Progression-free survival
Back to article page

Journal of Medical Case Reports

ISSN: 1752-1947